Advances in understanding mechanisms of toxicity and implications for risk assessment

Reproductive Toxicology

Volumn 11, Issue 2-3, 1997, Pages 389-396

  Daston, George P ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

developmental toxicity; mechanism of action; risk assessment

Indexed keywords

2 IMIDAZOLIDINETHIONE; BORIC ACID; TERATOGENIC AGENT; TOXIC SUBSTANCE;

ANIMAL; CHEMICAL TERATOGENESIS; CONFERENCE PAPER; CONGENITAL MALFORMATION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYO PATTERN FORMATION; EMBRYOTOXICITY; HUMAN; MORPHOGENESIS; NONHUMAN; ORGANOGENESIS; RISK ASSESSMENT; SPECIES DIFFERENCE; STATISTICS; TOXICITY TESTING; XENOBIOTIC METABOLISM;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BORIC ACIDS; ETHYLENETHIOUREA; HUMANS; RISK ASSESSMENT; STATISTICS; TERATOGENS;

ANIMALIA;

EID: 0031106196     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(96)00153-0     Document Type: Conference Paper

References (48)

1. Lehman-McKeeman LD. Male rat-specific light hydrocarbon nephropathy. In: Hook JB, Goldstein RS, eds. Toxicology of the kidney, 2nd ed. New York: Raven Press; 1993:477-94.
2. Neubert R, Neubert D. Peculiarities and possible mode of the action of thalidomide. In: Kavlock RJ, Daston GP, eds. Drug toxicity in embryonic development. Heidelberg: Springer Verlag; 1996;2:41-119.
3. Khera KS. Ethylenethiourea: teratogenicity study in rats and rabbits. Teratology. 1973;7:243-52.
4. Ruddick JA, Khera KS. Pattern of anomalies following single oral doses of ethylenethiourea to pregnant rats. Teratology. 1975;12: 277-82.
5. Teramoto S, Harada T, Kaneda M. Effects of ethylenethiourea upon developing brain and limb buds in the rat. Cong Anom. 1978;18:241-9.
6. Chernoff N, Kavlock RJ, Rogers EH, Carver BD, Murray S. Perinatal toxicity of maneb, ethylenethiourea, and ethylenebisisothio-cyanate sulfide in rodents. J Toxicol Environ Health. 1979;5:821-34.
7. Khera KS. Ethylenethiourea-induced hind paw deformities in mice and effects of metabolic modifiers on their occurrence. J Toxicol Environ Health. 1984;13:747-56.
8. Khera KS, Iverson F. Toxicity of ethylenethiourea in pregnant cats. Teratology. 1978;18:311-4.
9. Khera KS, Whalen C, Iverson F. Effects of pretreatment with SKF-525A, N-methyl-2-thiomidazole, sodium phenobarbital, or 3-methylcholanthrene on ethylenethiourea-induced teratogenicity in hamsters. J Toxicol Environ Health. 1983;11:287-300.
10. Ruddick JA, Newsome WH, Iverson F. A comparison of the distribution, metabolism and excretion of ethylenethiourea in the pregnant mouse and rat. Teratology. 1977;16:159-62.
11. Daston GP, Ebron MT, Carver B, Stefanadis JG. In vitro teratogenicity of ethylenethiourea in the rat. Teratology. 1987;35:239-45.
12. Daston GP, Yonker JE, Powers JF, Heitmeyer SA. Difference in teratogenic potency of ethylenethiourea in rats and mice: relative contribution of embryonic and maternal factors. Teratology. 1989; 40:555-66.
13. Scott MP, Tamkun JW, Hartzell GW III. The structure and function of the homeo domain. Biochem Biophys Acta. 1989;989:25-48.
14. Roelink H, Augsburger A, Heemskerk J, Korzh V, Norlin S, Ruizi Altaba A, Tanabe Y, Placzek M, Edlund T, Jessell TM, Dodd J. Floor plate and motor neuron induction by vhh-1, a vertebrate homolog of hedgehog expressed by the notochord. Cell. 1994;76: 761-75.
15. Hanks M, Wurst W, Anson-Cartwright L, Auerbach AB, Joyner AL. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science. 1995;269:679-82.
16. Courtney KD, Moore JA. Teratology studies with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol. 1971;20:396-403.
17. Sparschu GL, Dunn FL, Rowe VK. Study of the teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat. Fundam Cosmet Toxicol. 1971;9:405-12.
18. Giavini E, Prati M, Vismara C. Rabbit teratology study with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ Res. 1982;27:74-8.
19. Schweiz BA, Morris JM, Sparschu GL, Rowe VK, Gehring PJ, Emerson JL, Gerbig CG. Toxicology of chlorinated dibenzo-p-dioxins. Environ Health Perspect. 1973;5:87-99.
20. Mastroiacovo P, Spagnolo A, Marni E, Meazza L, Bertollini R, Segni G. Birth defects in the Seveso area after TCDD contamination. JAMA. 1988;259:1668-72.
21. Abbott BD, Birnbaum LS. TCDD exposure of human embryonic palatal shelves in organ culture alters the differentiation of medial epithelial cells. Teratology. 1991;43:119-32.
22. Savitsky K, Bar-Shira A, Gilad S, Rutman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995; 268:1749-53.
23. Pelletier J, Bruening W, Kashtan CE, Maurer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Hausman D. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991;67: 437-47.
24. Tassabehji M, Read AP, Newton VE, Harris R, Balling R, Grass P, Strachan T. Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature. 1992; 355:635-36.
25. Baldwin CT, Hoth CF, Amos JA, Da Silva ED, Milunsky A. An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature. 1992;355:637-8.
26. Buehler BA, Delimont D, van Waes M, Finnell RH. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med. 1990;322:1567-72.
27. Raymond GV, Buehler BA, Finnell RH, Holmes LB. Anticonvulsant ssssseratogenesis: 3. Possible metabolic basis [letter]. Teratology. 1995;51:55-6.
28. Boncinelli E, Simeone A, Acampora D, Mavilio F. Hox gene activation by retinoic acid. Trends Genet. 1991;7:329-34.
29. Small KM, Potter SS. Homeotic transformations and limb defects in Hox A11 mutant mice. Genes Dev. 1993;7:2318-28.
30. Davis AP, Capecchi MR. Axial homeosis and appendicular skeleton defects in mice with a targeted disruption of Hox d11. Development. 1994; 120:2187-98.
31. Davis AP, Witte DP, Hsieh-Li HM, Potter SS, Capecchi MR. Absence of radius and ulna in mice lacking hox a11 and hox d11. Nature. 1995;375:791-5.
32. Moase CE, Trasler DG. N-CAM alterations in Splotch neural tube defect mouse embryos. Development. 1991;113:1049-58.
33. Daston GP, Lamar E, Olivier M, Goulding M. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development. 1996;122:1017-27.
34. Kapron-Bras CM, Trasler DG. Gene-teratogen interaction and its morphological basis in retinoic acid-induced mouse spina bifida. Teratology. 1984;30:143-50.
35. Hwang SJ, Beaty TH, Panny SR, Street NA, Joseph JM, Gordon S, McIntosh I, Francomano CA. Association study of transforming growth factor alpha (TGF alpha) Taq 1 polymorphism and oral clefts: indication of gene-environment interaction in a populationbased sample of infants with birth defects. Am J Epidemiol. 1995; 141:629-36.
36. Klaassen CD, Lehman-McKeeman LD. Induction of metallothionein. J Am Coll Toxicol. 1989;8:1315-21.
37. Keen CL, Taubeneck MW, Daston GP, Rogers JM, Gershwin ME. Primary and secondary zinc deficiency as factors underlying abnormal CNS development. Ann NY Acad Sci. 1993;678:37-47.
38. Amemiya K, Keen CL, Hurley LS. 6-Mercaptopurine induced alterations in mineral metabolism and teratogenesis in the rat. Teratology. 1986;34:321-34.
39. Keen CL, Peters JM, Hurley LS. The effect of valproic acid on 65Zn distribution in the pregnant rat. J Nutr. 1989; 119:607-11.
40. Daston GP, Overmann GJ, Taubeneck MW, Lehman-McKeeman LD, Rogers JM, Keen CL. The role of metallothionein induction and altered zinc status in maternally mediated developmental toxicity: comparison of the effects of styrene and urethane in rats. Toxicol Appl Pharmacol. 1991;110:450-63.
41. Daston GP, Overmann GJ, Baines D, Taubeneck MW, Lehman-McKeeman LD, Rogers JM, Keen CL. Altered Zn status by α-hederin in the pregnant rat and its relationship to adverse developmental outcome. Reprod Toxicol. 1994;8:15-24.
42. Taubeneck MW, Daston GP, Rogers JM, Keen CL. Altered maternal zinc metabolism following exposure to diverse developmental toxicants. Reprod Toxicol. 1994;8:25-40.
43. Taubeneck MW, Daston GP, Rogers JM, Gershwin ME, Ansari A, Keen CL. Tumor necrosis factor-alpha alters maternal and embryonic zinc metabolism and is developmentally toxic in mice. J Nutr. 1995; 125:908-19.
44. Kessel M, Gruss P. Homeotoic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell. 1991;67:89-104.
45. Kessel M. Respecification of vertebral identities by retinoic acid. Development. 1992;115:487-501.
46. Heindel JJ, Price CJ, Field EA, Marr MC, Myers CB, Morrisey RE, Schweiz BA. Developmental toxicity of boric acid in mice and rats. Fundam Appl Toxicol. 1992;18:266-77.
47. Narotsky MG, Hamby BT, Mitchell DS, Kavlock RJ. Effects of boric acid on axial skeletal development in rats. Teratology. 1995; 51:192.
48. Alien BC, Strong PL, Price CJ, Hubbard SA, Daston GP. Benchmark dose analysis of developmental toxicity in rats exposed to boric acid. Fundam Appl Toxicol. 1996 (in press).